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Adrenomedullin is a vasodilatory polypeptide with
pleiotropic effects secreted by various organs.
Adrenomedullin is produced first as a prepropeptide,
and then cleaved into mature adrenomedullin and
mid-regional proadrenomedullin. Whereas levels of
the latter have been shown to correlate with severity
of sepsis and carry prognostic value, adrenomedullin
plays a role in vascular tone homeostasis. In the
previous issue of Critical Care, the infusion of
exogenous adrenomedullin is suggested to protect
against increased lung endothelial permeability and
end-organ dysfunction in a model of pneumococcal
pneumonia in mechanically ventilated mice,
possibly by stabilizing vascular endothelia. Since
adrenomedullin is a strong vasodilatory molecule,
further studies are needed to evaluate its potential as
a future treatment of sepsis.been shown in various rodent models, the addition ofIn the previous issue of Critical Care, Müller-Redetzky
and colleagues propose that adrenomedullin may be
promising to treat sepsis [1]. Adrenomedullin is a 52
amino acid polypeptide showing sequence homology with
other calcitonin-related peptides, discovered 20 years ago
as a secretion product of a pheochromocytoma. The
adrenomedullin gene encodes for a 185 amino acid pre-
propeptide, post-transcriptionally cleaved to produce the
bioactive, amidated adrenomedullin.
Adrenomedullin is found in plasma in health and at el-
evated concentrations during various pathologic condi-
tions, including cardiovascular and renal disorders,
sepsis, cancer, and diabetes [2]. This polypeptide has a
potent vasodilating effect and is believed to play a
physiological role in arterial pressure homeostasis.
Adrenomedullin exerts its effects via its ligation to the
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2014like receptor (CALCRL or CLR) in association with
RAMP2 or RAMP3 to form the adrenomedullin recep-
tors 1 and 2, respectively. Numerous pleiotropic effects
of adrenomedullin have been described: in tumor
growth, neovascularization, endothelium protection,
bronchodilation, fertility, and immunity [3].
Interestingly, the plasma concentration of a byproduct
of the preproadrenomedullin cleavage, the mid-regional
proadrenomedullin, has been used as a prognostic
marker, alone or in risk stratification with other propep-
tides such as procalcitonin, in children and in adult pa-
tients with sepsis and severe pneumonia [4]. This
biomarker is now commercially available.
Müller-Redetzky and colleagues propose that adreno-
medullin treatment is beneficial in a mouse model of
pneumococcal pneumonia and ventilator-induced lung
injury [1]. In a previous report, the same group had
already shown that adrenomedullin treatment attenuated
ventilator-induced lung injury in mice [5]. As has already
mechanical ventilation to pneumonia worsened the out-
come, in particular by inducing severe lung injury, sep-
sis, and end-organ dysfunction [6,7]. In the study by
Müller-Redetzky and colleagues, the infusion of adreno-
medullin was associated with decreased alveolar barrier
permeability, and protective effects on end organs such
as the liver and gut, suggested by lower transaminase
plasma levels and less cell death on histology [1].
Adrenomedullin treatment did not ameliorate the kidney
function, however, and nor did it influence lung
and blood bacterial burden or lung cytokine levels.
Adrenomedullin infusion did not significantly impact on
macrohemodynamics in this model. The authors postu-
late that most of the beneficial effects observed with
adrenomedullin treatment could be due to a stabilization
of endothelial integrity.
Preserving or restoring endothelial function in sepsis
and lung injury has been a holy grail for a long period of
time. Whereas the restoration of macrohemodynamics is
usually achieved with fluid loading, vasopressors, and
sometimes cardiotonic agents in patients with sepsis,e licensee has exclusive rights to distribute this article, in any medium, for 12
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adequate supply of oxygen and nutrients to tissues. The
implication of endothelial cells is central to this syndrome.
The cells control vascular tone in a nitric oxide-
dependent manner - and therefore arterial pressure - and
also control the permeability of capillaries. Endothelial
cells are activated during the initial phase of sepsis, plug-
ging capillaries with circulating leukocytes. The endothe-
lium also becomes leaky due to disruption of intercellular
junctions and endothelial cell death. Microcirculation im-
proves with microbiological source control and resolution
of the sepsis syndrome, the negativation of the fluid bal-
ance being a positive sign of sepsis resolution.
Adrenomedullin treatment offers hope for restoring
endothelial stability because it may prevent undesired
decompartmentalization of the inflammatory reaction
present in infected organs, and in the lung in particular.
One should, however, keep in mind that adrenomedullin
is a strong vasodilatory molecule, which will certainly
not be easy to use in shocked patients. In addition,
blocking adrenomedullin has also been shown to have a
positive impact in mice with cecal ligature and puncture,
improving catecholamine responsiveness, blunting the
shock-related impairment of energy metabolism, redu-
cing nitrosative stress, and attenuating systemic inflam-
matory response [8]. Caution is therefore mandatory
with the development of adrenomedullin as a drug, as
with any new treatment for sepsis.
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